APO Research

APO RESEARCH · REPORT

Medical Toxicology Service

Selected research

Market Analysis & Forecast

Global Medical Toxicology Service Market Analysis and Forecast 2026-2032

Market perspective

The global Medical Toxicology Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Medical Toxicology Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Medical Toxicology Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Medical Toxicology Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Medical Toxicology Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Medical Toxicology Service include Charles River, Labcorp, Envigo, MPI Research, Eurofins, Wuxi Apptec, SGS, Merck and Evotec, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Medical Toxicology Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Medical Toxicology Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Medical Toxicology Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Medical Toxicology Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Medical Toxicology Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Medical Toxicology Service revenue, projected growth trends, production technology, application and end-user industry.

Medical Toxicology Service Segment by Company

Charles River

Labcorp

Envigo

MPI Research

Eurofins

Wuxi Apptec

SGS

Merck

Evotec

Bureau Veritas

Medical Toxicology Service Segment by Type

Systemic Toxicology

Developmental & Reproductive Toxicology

Medical Toxicology Service Segment by Application

Pharmaceutical

Medical Devices

Cosmetic

Chemical

Medical Toxicology Service Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Toxicology Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Toxicology Service and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Toxicology Service.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Medical Toxicology Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Medical Toxicology Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medical Toxicology Service revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Medical Toxicology Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Systemic Toxicology Major Player Table 3. Developmental & Reproductive Toxicology Major Player Table 4. Global Medical Toxicology Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Pharmaceutical Major Player Table 6. Medical Devices Major Player Table 7. Cosmetic Major Player Table 8. Chemical Major Player Table 9. Medical Toxicology Service Industry Trends Table 10. Medical Toxicology Service Industry Drivers Table 11. Medical Toxicology Service Industry Opportunities and Challenges Table 12. Medical Toxicology Service Industry Restraints Table 13. Global Medical Toxicology Service Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Medical Toxicology Service Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Medical Toxicology Service Market Share by Region (2021-2026) Table 16. Global Medical Toxicology Service Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Medical Toxicology Service Market Share by Region (2027-2032) Table 18. Global Medical Toxicology Service Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Medical Toxicology Service Revenue Market Share by Players (2021-2026) Table 20. Global Medical Toxicology Service Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Medical Toxicology Service Key Players Headquarters & Area Served Table 22. Global Medical Toxicology Service Players, Product Type & Application Table 23. Global Medical Toxicology Service Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Medical Toxicology Service by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Medical Toxicology Service Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Medical Toxicology Service Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Medical Toxicology Service Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Medical Toxicology Service Revenue Market Share by Type (2021-2026) Table 30. Global Medical Toxicology Service Revenue Market Share by Type (2027-2032) Table 31. Global Medical Toxicology Service Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Medical Toxicology Service Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Medical Toxicology Service Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Medical Toxicology Service Revenue Market Share by Application (2021-2026) Table 35. Global Medical Toxicology Service Revenue Market Share by Application (2027-2032) Table 36. Charles River Company Information Table 37. Charles River Business Overview Table 38. Charles River Medical Toxicology Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Charles River Medical Toxicology Service Product Portfolio Table 40. Charles River Recent Development Table 41. Labcorp Company Information Table 42. Labcorp Business Overview Table 43. Labcorp Medical Toxicology Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Labcorp Medical Toxicology Service Product Portfolio Table 45. Labcorp Recent Development Table 46. Envigo Company Information Table 47. Envigo Business Overview Table 48. Envigo Medical Toxicology Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Envigo Medical Toxicology Service Product Portfolio Table 50. Envigo Recent Development Table 51. MPI Research Company Information Table 52. MPI Research Business Overview Table 53. MPI Research Medical Toxicology Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. MPI Research Medical Toxicology Service Product Portfolio Table 55. MPI Research Recent Development Table 56. Eurofins Company Information Table 57. Eurofins Business Overview Table 58. Eurofins Medical Toxicology Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Eurofins Medical Toxicology Service Product Portfolio Table 60. Eurofins Recent Development Table 61. Wuxi Apptec Company Information Table 62. Wuxi Apptec Business Overview Table 63. Wuxi Apptec Medical Toxicology Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Wuxi Apptec Medical Toxicology Service Product Portfolio Table 65. Wuxi Apptec Recent Development Table 66. SGS Company Information Table 67. SGS Business Overview Table 68. SGS Medical Toxicology Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. SGS Medical Toxicology Service Product Portfolio Table 70. SGS Recent Development Table 71. Merck Company Information Table 72. Merck Business Overview Table 73. Merck Medical Toxicology Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Merck Medical Toxicology Service Product Portfolio Table 75. Merck Recent Development Table 76. Evotec Company Information Table 77. Evotec Business Overview Table 78. Evotec Medical Toxicology Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Evotec Medical Toxicology Service Product Portfolio Table 80. Evotec Recent Development Table 81. Bureau Veritas Company Information Table 82. Bureau Veritas Business Overview Table 83. Bureau Veritas Medical Toxicology Service Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Bureau Veritas Medical Toxicology Service Product Portfolio Table 85. Bureau Veritas Recent Development Table 86. North America Medical Toxicology Service Revenue by Type (2021-2026) & (US$ Million) Table 87. North America Medical Toxicology Service Revenue by Type (2027-2032) & (US$ Million) Table 88. North America Medical Toxicology Service Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Medical Toxicology Service Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Medical Toxicology Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Medical Toxicology Service Revenue by Country (2021-2026) & (US$ Million) Table 92. North America Medical Toxicology Service Revenue by Country (US$ Million) & (2027-2032) Table 93. Europe Medical Toxicology Service Revenue by Type (2021-2026) & (US$ Million) Table 94. Europe Medical Toxicology Service Revenue by Type (2027-2032) & (US$ Million) Table 95. Europe Medical Toxicology Service Revenue by Application (2021-2026) & (US$ Million) Table 96. Europe Medical Toxicology Service Revenue by Application (2027-2032) & (US$ Million) Table 97. Europe Medical Toxicology Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe Medical Toxicology Service Revenue by Country (2021-2026) & (US$ Million) Table 99. Europe Medical Toxicology Service Revenue by Country (US$ Million) & (2027-2032) Table 100. China Medical Toxicology Service Revenue by Type (2021-2026) & (US$ Million) Table 101. China Medical Toxicology Service Revenue by Type (2027-2032) & (US$ Million) Table 102. China Medical Toxicology Service Revenue by Application (2021-2026) & (US$ Million) Table 103. China Medical Toxicology Service Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia Medical Toxicology Service Revenue by Type (2021-2026) & (US$ Million) Table 105. Asia Medical Toxicology Service Revenue by Type (2027-2032) & (US$ Million) Table 106. Asia Medical Toxicology Service Revenue by Application (2021-2026) & (US$ Million) Table 107. Asia Medical Toxicology Service Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia Medical Toxicology Service Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia Medical Toxicology Service Revenue by Region (US$ Million) & (2021-2026) Table 110. Asia Medical Toxicology Service Revenue by Region (US$ Million) & (2027-2032) Table 111. SAMEA Medical Toxicology Service Revenue by Type (2021-2026) & (US$ Million) Table 112. SAMEA Medical Toxicology Service Revenue by Type (2027-2032) & (US$ Million) Table 113. SAMEA Medical Toxicology Service Revenue by Application (2021-2026) & (US$ Million) Table 114. SAMEA Medical Toxicology Service Revenue by Application (2027-2032) & (US$ Million) Table 115. SAMEA Medical Toxicology Service Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. SAMEA Medical Toxicology Service Revenue by Country (2021-2026) & (US$ Million) Table 117. SAMEA Medical Toxicology Service Revenue by Country (US$ Million) & (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Medical Toxicology Service Image Figure 2. Global Medical Toxicology Service Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Toxicology Service Market Size Share 2021 VS 2025 VS 2032 Figure 4. Systemic Toxicology Image Figure 5. Developmental & Reproductive Toxicology Image Figure 6. Global Medical Toxicology Service Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Medical Toxicology Service Market Size Share 2021 VS 2025 VS 2032 Figure 8. Pharmaceutical Image Figure 9. Medical Devices Image Figure 10. Cosmetic Image Figure 11. Chemical Image Figure 12. Global Medical Toxicology Service Market Size (US$ Million) & (2021-2032) Figure 13. Global Medical Toxicology Service Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Medical Toxicology Service Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Medical Toxicology Service Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Medical Toxicology Service Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Medical Toxicology Service Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Medical Toxicology Service Revenue Market Share by Type (2021-2032) Figure 20. Global Medical Toxicology Service Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Medical Toxicology Service Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Medical Toxicology Service Revenue Market Share by Application (2021-2032) Figure 23. North America Medical Toxicology Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Medical Toxicology Service Revenue Share by Type (2021-2032) Figure 25. North America Medical Toxicology Service Revenue Share by Application (2021-2032) Figure 26. North America Medical Toxicology Service Revenue Share by Country (2021-2032) Figure 27. United States Medical Toxicology Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Medical Toxicology Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Medical Toxicology Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Medical Toxicology Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Medical Toxicology Service Revenue Share by Type (2021-2032) Figure 32. Europe Medical Toxicology Service Revenue Share by Application (2021-2032) Figure 33. Europe Medical Toxicology Service Revenue Share by Country (2021-2032) Figure 34. Germany Medical Toxicology Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Medical Toxicology Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Medical Toxicology Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Medical Toxicology Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Medical Toxicology Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Medical Toxicology Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Medical Toxicology Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Medical Toxicology Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Medical Toxicology Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Medical Toxicology Service Revenue Share by Type (2021-2032) Figure 44. China Medical Toxicology Service Revenue Share by Application (2021-2032) Figure 45. Asia Medical Toxicology Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Medical Toxicology Service Revenue Share by Type (2021-2032) Figure 47. Asia Medical Toxicology Service Revenue Share by Application (2021-2032) Figure 48. Asia Medical Toxicology Service Revenue Share by Region (2021-2032) Figure 49. Japan Medical Toxicology Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Medical Toxicology Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Medical Toxicology Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Medical Toxicology Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Medical Toxicology Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Medical Toxicology Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Medical Toxicology Service Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Medical Toxicology Service Revenue Share by Type (2021-2032) Figure 57. SAMEA Medical Toxicology Service Revenue Share by Application (2021-2032) Figure 58. SAMEA Medical Toxicology Service Revenue Share by Country (2021-2032) Figure 59. Brazil Medical Toxicology Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Medical Toxicology Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Medical Toxicology Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Medical Toxicology Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Medical Toxicology Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Medical Toxicology Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Medical Toxicology Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Medical Toxicology Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Medical Toxicology Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Medical Toxicology Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Medical Toxicology Service Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Systemic Toxicology
  • Developmental & Reproductive Toxicology
Applications
  • Pharmaceutical
  • Medical Devices
  • Cosmetic
  • Chemical
Companies covered
  • Charles River
  • Labcorp
  • Envigo
  • MPI Research
  • Eurofins
  • Wuxi Apptec
  • SGS
  • Merck
  • Evotec
  • Bureau Veritas

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Medical Toxicology Service Market by Type
  3. 1.2.1 Global Medical Toxicology Service Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Systemic Toxicology
  5. 1.2.3 Developmental & Reproductive Toxicology
  6. 1.3 Medical Toxicology Service Market by Application
  7. 1.3.1 Global Medical Toxicology Service Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Pharmaceutical
  9. 1.3.3 Medical Devices
  10. 1.3.4 Cosmetic
  11. 1.3.5 Chemical
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Medical Toxicology Service Market Dynamics
  1. 2.1 Medical Toxicology Service Industry Trends
  2. 2.2 Medical Toxicology Service Industry Drivers
  3. 2.3 Medical Toxicology Service Industry Opportunities and Challenges
  4. 2.4 Medical Toxicology Service Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Medical Toxicology Service Market Perspective (2021-2032)
  2. 3.2 Global Medical Toxicology Service Growth Trends by Region
  3. 3.2.1 Global Medical Toxicology Service Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Medical Toxicology Service Market Size by Region (2021-2026)
  5. 3.2.3 Global Medical Toxicology Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Medical Toxicology Service Revenue by Players
  2. 4.1.1 Global Medical Toxicology Service Revenue by Players (2021-2026)
  3. 4.1.2 Global Medical Toxicology Service Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Medical Toxicology Service Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Medical Toxicology Service Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Medical Toxicology Service Key Players Headquarters & Area Served
  7. 4.4 Global Medical Toxicology Service Players, Product Type & Application
  8. 4.5 Global Medical Toxicology Service Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Medical Toxicology Service Market CR5 and HHI
  11. 4.6.3 2025 Medical Toxicology Service Tier 1, Tier 2, and Tier 3
5 Medical Toxicology Service Market Size by Type
  1. 5.1 Global Medical Toxicology Service Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Medical Toxicology Service Revenue by Type (2021-2032)
  3. 5.3 Global Medical Toxicology Service Revenue Market Share by Type (2021-2032)
6 Medical Toxicology Service Market Size by Application
  1. 6.1 Global Medical Toxicology Service Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Medical Toxicology Service Revenue by Application (2021-2032)
  3. 6.3 Global Medical Toxicology Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Charles River
  2. 7.1.1 Charles River Company Information
  3. 7.1.2 Charles River Business Overview
  4. 7.1.3 Charles River Medical Toxicology Service Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Charles River Medical Toxicology Service Product Portfolio
  6. 7.1.5 Charles River Recent Developments
  7. 7.2 Labcorp
  8. 7.2.1 Labcorp Company Information
  9. 7.2.2 Labcorp Business Overview
  10. 7.2.3 Labcorp Medical Toxicology Service Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Labcorp Medical Toxicology Service Product Portfolio
  12. 7.2.5 Labcorp Recent Developments
  13. 7.3 Envigo
  14. 7.3.1 Envigo Company Information
  15. 7.3.2 Envigo Business Overview
  16. 7.3.3 Envigo Medical Toxicology Service Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Envigo Medical Toxicology Service Product Portfolio
  18. 7.3.5 Envigo Recent Developments
  19. 7.4 MPI Research
  20. 7.4.1 MPI Research Company Information
  21. 7.4.2 MPI Research Business Overview
  22. 7.4.3 MPI Research Medical Toxicology Service Revenue and Gross Margin (2021-2026)
  23. 7.4.4 MPI Research Medical Toxicology Service Product Portfolio
  24. 7.4.5 MPI Research Recent Developments
  25. 7.5 Eurofins
  26. 7.5.1 Eurofins Company Information
  27. 7.5.2 Eurofins Business Overview
  28. 7.5.3 Eurofins Medical Toxicology Service Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Eurofins Medical Toxicology Service Product Portfolio
  30. 7.5.5 Eurofins Recent Developments
  31. 7.6 Wuxi Apptec
  32. 7.6.1 Wuxi Apptec Company Information
  33. 7.6.2 Wuxi Apptec Business Overview
  34. 7.6.3 Wuxi Apptec Medical Toxicology Service Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Wuxi Apptec Medical Toxicology Service Product Portfolio
  36. 7.6.5 Wuxi Apptec Recent Developments
  37. 7.7 SGS
  38. 7.7.1 SGS Company Information
  39. 7.7.2 SGS Business Overview
  40. 7.7.3 SGS Medical Toxicology Service Revenue and Gross Margin (2021-2026)
  41. 7.7.4 SGS Medical Toxicology Service Product Portfolio
  42. 7.7.5 SGS Recent Developments
  43. 7.8 Merck
  44. 7.8.1 Merck Company Information
  45. 7.8.2 Merck Business Overview
  46. 7.8.3 Merck Medical Toxicology Service Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Merck Medical Toxicology Service Product Portfolio
  48. 7.8.5 Merck Recent Developments
  49. 7.9 Evotec
  50. 7.9.1 Evotec Company Information
  51. 7.9.2 Evotec Business Overview
  52. 7.9.3 Evotec Medical Toxicology Service Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Evotec Medical Toxicology Service Product Portfolio
  54. 7.9.5 Evotec Recent Developments
  55. 7.10 Bureau Veritas
  56. 7.10.1 Bureau Veritas Company Information
  57. 7.10.2 Bureau Veritas Business Overview
  58. 7.10.3 Bureau Veritas Medical Toxicology Service Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Bureau Veritas Medical Toxicology Service Product Portfolio
  60. 7.10.5 Bureau Veritas Recent Developments
8 North America
  1. 8.1 North America Medical Toxicology Service Revenue (2021-2032)
  2. 8.2 North America Medical Toxicology Service Revenue by Type (2021-2032)
  3. 8.2.1 North America Medical Toxicology Service Revenue by Type (2021-2026)
  4. 8.2.2 North America Medical Toxicology Service Revenue by Type (2027-2032)
  5. 8.3 North America Medical Toxicology Service Revenue Share by Type (2021-2032)
  6. 8.4 North America Medical Toxicology Service Revenue by Application (2021-2032)
  7. 8.4.1 North America Medical Toxicology Service Revenue by Application (2021-2026)
  8. 8.4.2 North America Medical Toxicology Service Revenue by Application (2027-2032)
  9. 8.5 North America Medical Toxicology Service Revenue Share by Application (2021-2032)
  10. 8.6 North America Medical Toxicology Service Revenue by Country
  11. 8.6.1 North America Medical Toxicology Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Medical Toxicology Service Revenue by Country (2021-2026)
  13. 8.6.3 North America Medical Toxicology Service Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Medical Toxicology Service Revenue (2021-2032)
  2. 9.2 Europe Medical Toxicology Service Revenue by Type (2021-2032)
  3. 9.2.1 Europe Medical Toxicology Service Revenue by Type (2021-2026)
  4. 9.2.2 Europe Medical Toxicology Service Revenue by Type (2027-2032)
  5. 9.3 Europe Medical Toxicology Service Revenue Share by Type (2021-2032)
  6. 9.4 Europe Medical Toxicology Service Revenue by Application (2021-2032)
  7. 9.4.1 Europe Medical Toxicology Service Revenue by Application (2021-2026)
  8. 9.4.2 Europe Medical Toxicology Service Revenue by Application (2027-2032)
  9. 9.5 Europe Medical Toxicology Service Revenue Share by Application (2021-2032)
  10. 9.6 Europe Medical Toxicology Service Revenue by Country
  11. 9.6.1 Europe Medical Toxicology Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Medical Toxicology Service Revenue by Country (2021-2026)
  13. 9.6.3 Europe Medical Toxicology Service Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Medical Toxicology Service Revenue (2021-2032)
  2. 10.2 China Medical Toxicology Service Revenue by Type (2021-2032)
  3. 10.2.1 China Medical Toxicology Service Revenue by Type (2021-2026)
  4. 10.2.2 China Medical Toxicology Service Revenue by Type (2027-2032)
  5. 10.3 China Medical Toxicology Service Revenue Share by Type (2021-2032)
  6. 10.4 China Medical Toxicology Service Revenue by Application (2021-2032)
  7. 10.4.1 China Medical Toxicology Service Revenue by Application (2021-2026)
  8. 10.4.2 China Medical Toxicology Service Revenue by Application (2027-2032)
  9. 10.5 China Medical Toxicology Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Medical Toxicology Service Revenue (2021-2032)
  2. 11.2 Asia Medical Toxicology Service Revenue by Type (2021-2032)
  3. 11.2.1 Asia Medical Toxicology Service Revenue by Type (2021-2026)
  4. 11.2.2 Asia Medical Toxicology Service Revenue by Type (2027-2032)
  5. 11.3 Asia Medical Toxicology Service Revenue Share by Type (2021-2032)
  6. 11.4 Asia Medical Toxicology Service Revenue by Application (2021-2032)
  7. 11.4.1 Asia Medical Toxicology Service Revenue by Application (2021-2026)
  8. 11.4.2 Asia Medical Toxicology Service Revenue by Application (2027-2032)
  9. 11.5 Asia Medical Toxicology Service Revenue Share by Application (2021-2032)
  10. 11.6 Asia Medical Toxicology Service Revenue by Country
  11. 11.6.1 Asia Medical Toxicology Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Medical Toxicology Service Revenue by Country (2021-2026)
  13. 11.6.3 Asia Medical Toxicology Service Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Medical Toxicology Service Revenue (2021-2032)
  2. 12.2 SAMEA Medical Toxicology Service Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Medical Toxicology Service Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Medical Toxicology Service Revenue by Type (2027-2032)
  5. 12.3 SAMEA Medical Toxicology Service Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Medical Toxicology Service Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Medical Toxicology Service Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Medical Toxicology Service Revenue by Application (2027-2032)
  9. 12.5 SAMEA Medical Toxicology Service Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Medical Toxicology Service Revenue by Country
  11. 12.6.1 SAMEA Medical Toxicology Service Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Medical Toxicology Service Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Medical Toxicology Service Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research